Tang Xiaodong: Clinical Trials

2 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1, 1 Phase 4.

By phase and status

Phase	Trials	Status
Phase 2	2	Not yet recruiting 1, Recruiting 1
Phase 1	1	Recruiting 1
Phase 4	1	Not yet recruiting 1

Follow Tang Xiaodong: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
The Effect of Preoperative Intravenous Ferric Derisomaltose and EPO and Tranexamic Acid in Patients With Preoperative Anemia or Iron Deficiency in Bone Tumor isomaltose iron - Anemia	Phase 4	Not yet recruiting	Tang Xiaodong	160	2026-01-01	2026-01-02
A Randomized Controlled Study Comparing the Safety and Efficacy of Irinotecan Hydrochloride Liposome Injection Combined With Temozolomide and Vincristine (NALIRI-VT) Versus Irinotecan Combined With Temozolomide and Vincristine (VIT) in Patients With Advanced Ewing's Sarcoma Irinotecan Hydrochloride Liposome Injection Combined with Temozolomide and Vincristine (NALIRI-VT), Irinotecan Combined with Temozolomide and Vincristine (VIT) - Ewing's Sarcoma	Phase 2	Not yet recruiting	Tang Xiaodong	74	2025-08-10	2025-07-29
Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study ICG (Indocyanine Green) - Giant Cell Tumor of Bone	Phase 1 / Phase 2	Recruiting	Tang Xiaodong	45	2024-08-23	2024-10-18

Conditions studied

Anemia (1)  ·  Bone Neoplasms (1)  ·  Giant Cell Tumor of Bone (1)  ·  Sarcoma, Ewing (1)

Interventions

Indocyanine Green (1)  ·  Temozolomide (1)  ·  Vincristine (1)

Countries

China (1)